Leukaemia
An analysis of Leukapheresis as a prophylactic modality of therapy for ‘Tumor Lysis Syndrome’ compared to conventional management alone: A pilot open labelled Randomized control trial
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyStudy of how care is given
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 9 Dec 2024. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
All India Institute of Medical Sciences RaipurRaipur, ChhattisgarhDirections ↗
Registry summary (technical)
An analysis of Leukapheresis as a prophylactic modality of therapy for ‘Tumor Lysis Syndrome’ compared to conventional management: A pilot open labelled Randomized control trial - Trial acronym: DBULKT
Sponsor: All India Institute of Medical Sciences Raipur
CTRI/2023/03/050636 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 9 Dec 2024 · read by us 5 Nov 2026